Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II

被引:52
作者
vanDet, NF
Verhagen, NAM
Tamsma, JT
Berden, JHM
Bruijn, JA
Daha, MR
vanderWoude, FJ
机构
[1] UNIV LEIDEN HOSP,DEPT ENDOCRINOL,NL-2300 RC LEIDEN,NETHERLANDS
[2] UNIV LEIDEN HOSP,DEPT PATHOL,NL-2300 RC LEIDEN,NETHERLANDS
[3] UNIV NIJMEGEN HOSP,DEPT NEPHROL,NIJMEGEN,NETHERLANDS
[4] UNIV HEIDELBERG,KLINIKUM MANNHEIM,DEPT NEPHROL,HEIDELBERG,GERMANY
关键词
D O I
10.2337/diabetes.46.5.834
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Accumulation of matrix proteins is a prominent feature of diabetic nephropathy. Glomerular visceral epithelial cells (GVECs) are important contributors to extracellular matrix (ECM) production in the glomerulus. Factors involved with increased accumulation of ECM proteins are high glucose, angiotensin II (ANG II), and transforming growth factor (TGF)-beta. Therefore, we investigated the effects of high glucose and ANG II on fibronectin and TGF-beta production by human GVECs in vitro. We found that ANG II had no effect on the production of fibronectin and TGF-beta by GVECs. Using reverse transcriptase-polymerase chain reaction analysis, no ANG II receptor could be detected on these cells. However, high glucose induced a twofold increase in fibronectin (P < 0.01) and a three- to sixfold increase in TGF-beta (P < 0.001) production. Similar results were obtained by analyzing the mRNA levels of fibronectin (increased 2.7-fold) and TGF-beta (increased 3.5-fold). Addition of increasing concentrations of rTGF-beta to control cells resulted in increased fibronectin production. Neutralizing antibodies against TGF-beta significantly reversed the increase in fibronectin protein and mRNA caused by high glucose back to control levels. We conclude that high glucose concentrations stimulate the synthesis of fibronectin and that this effect is mediated by induction of TGF-beta. These results suggest that in diabetic nephropathy, high glucose levels play a role in changing the matrix composition of the glomerular basement membrane through induction of TGF-beta. Our results indicate that a contribution to this process by an effect of ANG II on GVECs seems unlikely.
引用
收藏
页码:834 / 840
页数:7
相关论文
共 62 条
[1]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[2]   CONTROL OF GLOMERULAR HYPERTENSION LIMITS GLOMERULAR INJURY IN RATS WITH REDUCED RENAL MASS [J].
ANDERSON, S ;
MEYER, TW ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (02) :612-619
[3]   INCREASED EXTRACELLULAR-MATRIX SYNTHESIS AND MESSENGER-RNA IN MESANGIAL CELLS GROWN IN HIGH-GLUCOSE MEDIUM [J].
AYO, SH ;
RADNIK, RA ;
GLASS, WF ;
GARONI, JA ;
RAMPT, ER ;
APPLING, DR ;
KREISBERG, JI .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (02) :F185-F191
[4]  
AYO SH, 1990, AM J PATHOL, V136, P1339
[5]   CLONING AND CHARACTERIZATION OF A HUMAN ANGIOTENSIN-II TYPE-1 RECEPTOR [J].
BERGSMA, DJ ;
ELLIS, C ;
KUMAR, C ;
NUTHULAGANTI, P ;
KERSTEN, H ;
ELSHOURBAGY, N ;
GRIFFIN, E ;
STADEL, JM ;
AIYAR, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (03) :989-995
[6]   DISTINCT LOCALIZATION OF ATRIAL-NATRIURETIC-FACTOR AND ANGIOTENSIN-II BINDING-SITES IN THE GLOMERULUS [J].
BIANCHI, C ;
GUTKOWSKA, J ;
THIBAULT, G ;
GARCIA, R ;
GENEST, J ;
CANTIN, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (04) :F594-F602
[7]   TRANSFORMING GROWTH FACTOR-B REGULATES PRODUCTION OF PROTEOGLYCANS BY MESANGIAL CELLS [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
RUOSLAHTI, E .
KIDNEY INTERNATIONAL, 1990, 37 (02) :689-695
[8]   SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1 [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
SPORN, MB ;
RUOSLAHTI, E .
NATURE, 1990, 346 (6282) :371-374
[9]   NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE [J].
BORDER, WA ;
NOBLE, NA ;
YAMAMOTO, T ;
HARPER, JR ;
YAMAGUCHI, Y ;
PIERSCHBACHER, MD ;
RUOSLAHTI, E .
NATURE, 1992, 360 (6402) :361-364
[10]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315